ASGE releases updated playbook for lower GI bleeding management

The American Society of Gastrointestinal Endoscopy (ASGE) has published updated 2026 guidance on the role of endoscopy in lower gastrointestinal bleeding (LGIB), shifting the clinical approach from rigid timing rules to a patient physiology-based framework. The guideline, published in Gastrointestinal Endoscopy, was developed using the GRADE evidence system and reflects how modern tools — particularly CT angiography — have reshaped bedside decision-making.

Key changes include dropping a fixed colonoscopy timing target in favor of scoping when the patient is stable and can tolerate full bowel prep, formally recognizing CT with contrast as an acceptable (and preferred, in unstable patients) first diagnostic test, and favoring direct clipping over cautery for visible diverticular vessels due to perforation risk in the thinner colonic wall. The guidance also includes a novel sustainability section, suggesting environmental impact as a tiebreaker when two options are clinically equivalent.

Key Takeaways:

• No fixed colonoscopy timing — scope when the patient is stable and bowel prep is feasible
• CT angiography is now a first-line option; preferred if the patient is hemodynamically unstable
• Direct clipping favored over cautery for visible diverticular vessels; cautery raises perforation risk
• Band ligation recommended only for proximal lesions by experienced operators — with caveats about limited device availability in North America
• Always rule out an upper GI source first in unstable patients with hematochezia (upper source found in ~15% of cases)

Why it matters: LGIB is notoriously difficult to manage — a bleeding source is identified and treated only 19–29% of the time at colonoscopy. This updated framework gives clinicians a practical, evidence-based algorithm that reduces pressure for unnecessary overnight scoping while ensuring the right patients get the right intervention at the right time.